Category: Science

All Podcast Categories
S4-E46.4 - The Liver Meeting 2023: Updates with Key Opinion Leader, Scott Isaacs MM

S4-E46.4 – The Liver Meeting 2023: Updates with Key Opinion Leader, Scott Isaacs MM

This week on Surfing NASH, host Roger Green embarks on a series of one on one interviews with KOLs and patient advocates to talk about the Liver Meeting 2023 (held in Boston from November 10 – 14) and much more. In this conversation, Key Opinion Leader, Scott Isaacs, joins to discuss this highly anticipated event as well as offer a glimpse into his current work and research interests.

S4-E46.2 - Anticipating TLM 2023 with Michael Betel

S4-E46.2 – Anticipating TLM 2023 with Michael Betel

This week on Surfing NASH, host Roger Green embarks on a series of one on one interviews with KOLs and patient advocates to talk about anticipations around the Liver Meeting 2023 (held in Boston from November 10 – 14) and much more. In this session, President of the Fatty Liver Alliance, Michael Betel,  joins to discuss this highly anticipated event, plus some additional key ideas around patient advocacy.

S4-E46.1 - The Liver Meeting 2023: Updates with Key Opinion Leader, Jörn Schattenberg

S4-E46.1 – The Liver Meeting 2023: Updates with Key Opinion Leader, Jörn Schattenberg

This week on Surfing NASH, host Roger Green embarks on a series of one on one interviews with KOLs and patient advocates to talk about the Liver Meeting 2023 (held in Boston from November 10 – 14) and much more. In this first conversation, Jörn Schattenberg joins to discuss this highly anticipated event as well as offer a glimpse into his current work and research interests.

S4-E45.1 - Meeting Professor Oren Shibolet

S4-E45.1 – Meeting Professor Oren Shibolet

In continuation of the Surfing NASH interview series, this week Roger Green talks to Professor Oren Shibolet, Head of Gastroenterology and Hepatology at the Tel Aviv Medical Center.

S4-E44.2 - Investigating False Negative Screening Rates

S4-E44.2 – Investigating False Negative Screening Rates

This conversation starts with your Jörn returning to a key point from Roberta’s paper around a 38% false negative rate for FIB-4 screening. Jörn notes that while this feels like a high rate for false negatives, it might not present as much of a diagnostic challenge if treaters repeat the screening every 2 to 3 years.

S4-E44 - Screening Strategies for Gender-Based SLD Challenges

S4-E44 – Screening Strategies for Gender-Based SLD Challenges

In a recent SurfingNASH episode, Dr. Roberta Forlano, celebrated for her hepatology research and EASL Juan Rodes PhD Fellowship, delves into critical aspects of NAFLD, from screening strategies in primary care to non-invasive markers, alongside experts Jörn Schattenberg, Louise Campbell, and Roger Green. The discussions, centered on screening strategies for gender-specific SLD challenges, also showcase Roberta’s team’s notable contributions to the SLD Summit. A must-listen for those interested in advanced hepatology topics and research developments.

S4-E43.4 - Michelle Long on Academia vs Industry

S4-E43.4 – Michelle Long on Academia vs Industry

This week, SurfingNASH offers an episode comprising two seperate interviews which focus on stories around career trajectories, transitions and entrepreneurship. Host Roger Green talks with Rachel Zayas (AGED Diagnostics) and Michelle Long (Novo Nordisk) about their unique stories and creating new opportunities amidst a field with broadening but sometimes opaque horizons.

S4-E43.2 - CEO Rachel Zayas on Fundraising and Venture Competitions

S4-E43.2 – CEO Rachel Zayas on Fundraising and Venture Competitions

This week, SurfingNASH offers an episode comprising two seperate interviews which focus on stories around career trajectories, transitions and entrepreneurship. Host Roger Green talks with Rachel Zayas (AGED Diagnostics) and Michelle Long (Novo Nordisk) about their unique stories and creating new opportunities amidst a field with broadening but sometimes opaque horizons.